Troikaa Pharmaceuticals Limited, a active public limited company, was established on 31 May 1994 in Ahmadabad City, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100GJ1994PLC022162. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹68.00 Cr and a paid-up capital of ₹62.55 Cr.
Formerly known as Troikaa Exports Limited, Troikaa Exports Pvt Ltd. It upholds a compliant status. Employing 3,558 professional, Its leadership includes Achyutkumar Dadubhai Patel (Whole-Time Director), Subir Kumar Das (Director), Asheel Ketan Patel (Whole-Time Director). Past directors included Achyutkumar Dadubhai Patel, Subir Kumar Das, Asheel Ketan Patel. It holds ₹817.99 Cr open charges and ₹111.56 Cr settled loans. Its latest AGM occurred on 06 August 2025, with the balance sheet filed on 31 March 2025. It is based at Troikaa House, Commerce House-1, Satya Marg,, Ahmadabad City, Gujarat, 380054.
U24100GJ1994PLC022162
022162
31 May 1994
₹68.00 Cr
₹62.55 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Troikaa Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Achyutkumar Dadubhai Patel | Whole-Time Director | 24 Oct 2015 | Current |
| Subir Kumar Das | Director | 03 Feb 2020 | Current |
| Asheel Ketan Patel | Whole-Time Director | 01 Apr 2021 | Current |
| Prakash Jayantilal Shah | Director | 08 Aug 2023 | Current |
| Padmin Hasitkant Buch | Director | 02 May 2016 | Current |
| Ketan Rajnikant Patel | Managing Director | 31 May 1994 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 02 May 2016 | Past |
| Pramod Abcsdd | Additional Director | 15 Oct 2020 | Past |
| Pramod Abcsdd | Additional Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Director | 30 Apr 2022 | Past |
| Pramod Abcsdd | Cfo(Kmp) | 19 Oct 2019 | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Troikaa Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.99% increase. The company also saw a substantial improvement in profitability, with a 72.22% increase in profit. The company's net worth dipped by a decrease of 0.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Troikaa Pharmaceuticals had a promoter holding of 97.59% and a public holding of 2.41%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,179,874,064.00
₹1,115,647,398.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Oct 2025 | Hdfc Bank Limited | ₹3.35 M | Open |
| 14 Aug 2025 | Hdfc Bank Limited | ₹1.73 M | Open |
| 17 Jun 2025 | Hdfc Bank Limited | ₹1.73 M | Open |
| 15 May 2025 | Hdfc Bank Limited | ₹1.64 M | Open |
| 13 Mar 2025 | Others | ₹18.60 Cr | Open |
Explore comprehensive loan charge details -
Troikaa Pharmaceuticals has a workforce of 3558 employees as of Feb 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Troikaa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Troikaa Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.33 Cr with Charge ID 101172346 was registered on 17 Oct 2025. was documented.
The activity A charge with Others of Rs. 60.00 Cr registered on 27 Sep 2007 with Charge ID 10071482 was modified on 26 Sep 2025. was completed.
Progress on A charge registered on 30 Jan 2021 via Charge ID 100424043 with Hdfc Bank Limited was fully satisfied on 26 Aug 2025. was documented.
Progress on A charge registered on 30 Jan 2021 via Charge ID 100423839 with Hdfc Bank Limited was fully satisfied on 26 Aug 2025. was documented.
A charge registered on 26 Aug 2014 via Charge ID 10558452 with Hdfc Bank Limited was fully satisfied on 26 Aug 2025. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 101140163 was registered on 14 Aug 2025. was completed.
Troikaa pharmaceutical alleged that the approval for manufacturing and marketing of the injection is arbitrary in view of safety concerns over Transcutol.
The CIN of Troikaa Pharmaceuticals Limited is U24100GJ1994PLC022162.
Troikaa Pharmaceuticals Limited is headquartered at Troikaa House, Commerce House-1, Satya Marg,, Ahmadabad City, Gujarat, 380054.
Troikaa Pharmaceuticals Limited was incorporated on 31 May 1994.
The current directors of Troikaa Pharmaceuticals Limited are
The primary industry of Troikaa Pharmaceuticals Limited is Manufacturing.
Troikaa Pharmaceuticals Limited is unlisted.
The authorized capital of Troikaa Pharmaceuticals Limited is ₹68.00 Cr, and the paid-up capital is ₹62.55 Cr.
The compliance status of Troikaa Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX